These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 33621551)

  • 21. Adding radiation to induction chemotherapy does not improve survival of patients with operable clinical N2 non-small cell lung cancer.
    Yang CF; Gulack BC; Gu L; Speicher PJ; Wang X; Harpole DH; Onaitis MW; D'Amico TA; Berry MF; Hartwig MG
    J Thorac Cardiovasc Surg; 2015 Dec; 150(6):1484-92; discussion 1492-3. PubMed ID: 26259994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction chemotherapy followed by allogeneic HCT versus upfront allogeneic HCT for advanced myelodysplastic syndrome: A propensity score matched analysis.
    Konuma T; Shimomura Y; Ozawa Y; Ueda Y; Uchida N; Onizuka M; Akiyama M; Mori T; Nakamae H; Ohno Y; Shiratori S; Onishi Y; Kanda Y; Fukuda T; Atsuta Y; Ishiyama K;
    Hematol Oncol; 2019 Feb; 37(1):85-95. PubMed ID: 30370627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The timing of chemotherapy in the management plan for medically operable early-stage malignant pleural mesothelioma.
    Shohdy K; Abdel-Rahman O
    Expert Rev Respir Med; 2019 Jun; 13(6):579-584. PubMed ID: 30977408
    [No Abstract]   [Full Text] [Related]  

  • 24. Neoadjuvant sandwich treatment with oxaliplatin and capecitabine administered prior to, concurrently with, and following radiation therapy in locally advanced rectal cancer: a prospective phase 2 trial.
    Gao YH; Lin JZ; An X; Luo JL; Cai MY; Cai PQ; Kong LH; Liu GC; Tang JH; Chen G; Pan ZZ; Ding PR
    Int J Radiat Oncol Biol Phys; 2014 Dec; 90(5):1153-60. PubMed ID: 25442042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pathological downstaging and survival after induction chemotherapy and radical cystectomy for clinically node-positive bladder cancer-Results of a nationwide population-based study.
    Hermans TJ; Fransen van de Putte EE; Horenblas S; Meijer RP; Boormans JL; Aben KK; van der Heijden MS; de Wit R; Beerepoot LV; Verhoeven RH; van Rhijn BW
    Eur J Cancer; 2016 Dec; 69():1-8. PubMed ID: 27814469
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neoadjuvant therapy versus upfront surgery for resected pancreatic adenocarcinoma: A nationwide propensity score matched analysis.
    de Geus SW; Eskander MF; Bliss LA; Kasumova GG; Ng SC; Callery MP; Tseng JF
    Surgery; 2017 Mar; 161(3):592-601. PubMed ID: 28341441
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors and survival for pathologic tumor response grade in borderline resectable and locally advanced pancreatic cancer treated with induction chemotherapy and neoadjuvant stereotactic body radiotherapy.
    Mellon EA; Jin WH; Frakes JM; Centeno BA; Strom TJ; Springett GM; Malafa MP; Shridhar R; Hodul PJ; Hoffe SE
    Acta Oncol; 2017 Mar; 56(3):391-397. PubMed ID: 27885876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of Neoadjuvant Chemotherapy Followed by Surgery to Upfront Surgery for Thymic Malignancy.
    Park S; Park IK; Kim YT; Lee GD; Kim DK; Cho JH; Choi YS; Lee CY; Lee JG; Kang CH;
    Ann Thorac Surg; 2019 Feb; 107(2):355-362. PubMed ID: 30316850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A prospective, multi-institutional phase II study of induction chemoradiotherapy followed by surgery in patients with non-small cell lung cancer involving the chest wall (CJLSG0801).
    Kawaguchi K; Yokoi K; Niwa H; Ohde Y; Mori S; Okumura S; Shiono S; Ito H; Yano M; Shigemitsu K; Hiramatsu Y; Okami J; Saka H;
    Lung Cancer; 2017 Feb; 104():79-84. PubMed ID: 28213006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term outcomes of induction chemotherapy and neoadjuvant stereotactic body radiotherapy for borderline resectable and locally advanced pancreatic adenocarcinoma.
    Mellon EA; Hoffe SE; Springett GM; Frakes JM; Strom TJ; Hodul PJ; Malafa MP; Chuong MD; Shridhar R
    Acta Oncol; 2015 Jul; 54(7):979-85. PubMed ID: 25734581
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative Effectiveness of Neoadjuvant Chemoradiation Versus Upfront Surgery in the Management of Recto-Sigmoid Junction Cancer.
    Venigalla S; Chowdhry AK; Wojcieszynski AP; Lukens JN; Plastaras JP; Metz JM; Ben-Josef E; Mahmoud NN; Reiss KA; Shabason JE
    Clin Colorectal Cancer; 2018 Sep; 17(3):e557-e568. PubMed ID: 29910004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Trends in Neoadjuvant Approaches in Pancreatic Cancer.
    Du L; Wang-Gillam A
    J Natl Compr Canc Netw; 2017 Aug; 15(8):1070-1077. PubMed ID: 28784867
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cost effectiveness of neoadjuvant chemotherapy in locally advanced operable head and neck cancer followed by surgery and postoperative radiotherapy: a Markov model-based decision analysis.
    Himmel M; Hartmann M; Guntinas-Lichius O
    Oncology; 2013; 84(6):336-41. PubMed ID: 23652024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does a simple hematological examination predict the response and side effects in patients undergoing induction chemotherapy and/or neoadjuvant chemotherapy?
    Lee WL; Chan IS; Wang PH
    J Chin Med Assoc; 2020 Feb; 83(2):107-108. PubMed ID: 31868856
    [No Abstract]   [Full Text] [Related]  

  • 35. [Induction chemotherapy for locally advanced cervical cancer].
    Morkhov KY; Nechushkina VM; Kuznetsov VV
    Vopr Onkol; 2015; 61(2):208-13. PubMed ID: 26087600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does the use of induction chemotherapy in oral cavity cancer compromise subsequent loco-regional treatment delivery: Results from a matched pair analysis.
    Patil VM; Muttath G; Babu S; Kumar ST; Jones J; Sen S; Chakraborty S
    Indian J Cancer; 2015; 52(4):632-6. PubMed ID: 26960501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years' Experience.
    Opitz I; Friess M; Kestenholz P; Schneiter D; Frauenfelder T; Nguyen-Kim TD; Seifert B; Hoda MA; Klepetko W; Stahel RA; Weder W
    J Thorac Oncol; 2015 Nov; 10(11):1634-41. PubMed ID: 26317916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of neoadjuvant chemoradiation in early esophageal cancers.
    Mariette C; Robb WB
    Ann Thorac Surg; 2012 Oct; 94(4):1374-5. PubMed ID: 23006706
    [No Abstract]   [Full Text] [Related]  

  • 39. Revisiting induction chemotherapy before radiotherapy for head and neck cancer, part II: nasopharyngeal carcinoma.
    Chapman CH; Parvathaneni U; Yom SS
    Future Oncol; 2017 Mar; 13(7):581-584. PubMed ID: 28169580
    [No Abstract]   [Full Text] [Related]  

  • 40. Optimising radiation treatment decisions for patients who receive neoadjuvant chemotherapy and mastectomy.
    Hoffman KE; Mittendorf EA; Buchholz TA
    Lancet Oncol; 2012 Jun; 13(6):e270-6. PubMed ID: 22652235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.